TY - JOUR T1 - Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia JF - medRxiv DO - 10.1101/2021.04.19.21255709 SP - 2021.04.19.21255709 AU - Rachael H Dodd AU - Kristen Pickles AU - Erin Cvejic AU - Samuel Cornell AU - Jennifer MJ Isautier AU - Tessa Copp AU - Brooke Nickel AU - Carissa Bonner AU - Carys Batcup AU - Danielle M Muscat AU - Julie Ayre AU - Kirsten J McCaffery Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/27/2021.04.19.21255709.abstract N2 - Background Vaccination rollout against COVID-19 has begun across multiple countries worldwide. Although the vaccine is free, rollout might still be compromised by hesitancy or concerns about COVID-19 vaccines.Methods We conducted two online surveys of Australian adults in April (during national lockdown; convenience cross-sectional sample) and November (virtually no cases of COVID-19; nationally representative sample) 2020, prior to vaccine rollout. We asked about intentions to have a potential COVID-19 vaccine (If a COVID-19 vaccine becomes available, I will get it) and free-text responses (November only).Results After adjustment for differences in sample demographics, the estimated proportion agreeing to a COVID-19 vaccine if it became available in April (n=1146) was 76.2%. In November (n=2034) this was estimated at 71.4% of the sample; additional analyses identified that the variation was driven by differences in perceived public health threat between April and November. Across both surveys, female gender, being younger, having inadequate health literacy and lower education were associated with reluctance to be vaccinated against COVID-19. Lower perceived susceptibility to COVID-19, belief that data on the efficacy of vaccines is ‘largely made up’, having lower confidence in government, and lower perception of COVID-19 as a public health threat, were also associated with reluctance to be vaccinated against COVID-19. The top three reasons for agreeing to vaccinate (November only) were to protect myself and others, moral responsibility, and having no reason not to get it. For those who were indifferent or disagreeing to vaccinate, safety concerns were the top reason, followed by indecision and lack of trust in the vaccine respectively.CONCLUSIONS These findings highlight some factors related to willingness to accept a COVID-19 vaccine prior to one being available in Australia. Now that the vaccine is being offered, this study identifies key issues that can inform public health messaging to address vaccine hesitancy.HIGHLIGHTSPerceived public health threat is associated with intentions to vaccinateThose believing the efficacy of vaccines is made up were less willing to get vaccinatedTo protect myself and others was the top reason for getting the vaccineSafety concerns was the top reason against getting the vaccineCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was not specifically funded, but in-kind support was provided by authors with research fellowships. RD is supported by a University of Sydney fellowship (#197589). CB is supported by a National Health and Medical Research Council (NHMRC)/Heart Foundation Early Career Fellowship (#1122788). KM is supported by a National Health and Medical Research Council (NHMRC) Principal Research Fellowship (#1121110). The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the University of Sydney Human Research Ethics Committee (2020/212).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStudy data may be made available on request to accredited researchers who gain ethical approval. ER -